Jaguar Uranium Corp. Reports 2026 Annual Meeting Voting Results

What Happened
Jaguar Uranium Corp. (JAGU) held its 2026 Annual Meeting of Shareholders on September 22, 2026 (record date August 10, 2026). As of the record date there were 20,193,777 common shares outstanding; 12,526,454 shares (≈62.03%) were present or represented by proxy, constituting a quorum. Shareholders approved three proposals: (1) election of six directors, (2) an amendment to the Jaguar Uranium Corp. 2025 Equity Incentive Plan, and (3) ratification of Davidson & Company LLP as the company’s independent registered public accounting firm for fiscal 2026.

Key Details

• Record date and turnout: 20,193,777 shares outstanding; 12,526,454 votes represented (≈62.03% of outstanding).
• Director elections (votes For / Votes Withheld / Broker Non-votes where reported):
  • Luis Ducassi: 9,571,127 For; 1,782,116 Withheld; 1,173,211 Broker non-votes
  • Steven Gold: 9,572,455 For; 1,780,788 Withheld; 1,173,211 Broker non-votes
  • Trumbull Fisher: 9,572,455 For; 1,780,788 Withheld; 1,173,211 Broker non-votes
  • Janet Meiklejohn: 11,339,315 For; 13,928 Withheld; 1,173,211 Broker non-votes
  • Max Leclerc: 11,339,715 For; 13,528 Withheld; 1,173,211 Broker non-votes
  • Tomas De Pablos Souza: 11,338,737 For; 14,506 Withheld
• Equity plan amendment (Proposal 2): 10,041,020 For; 1,312,222 Against; 0 Abstentions; 1,173,211 Broker non-votes.
• Auditor ratification (Proposal 3): 12,478,418 For; 0 Against; 48,035 Abstained; 1 Broker non-vote.

Why It Matters
These votes confirm shareholder approval of Jaguar Uranium’s current board slate and governance actions. Approval of the 2025 Equity Incentive Plan amendment allows the company to continue granting equity awards (which can affect future share dilution and employee/executive compensation). Ratifying the auditor maintains continuity for the company’s financial reporting for fiscal 2026. Investors should note the vote totals and turnout as indicators of shareholder support for management and governance proposals.